SNYRHIGH SIGNALFINANCIAL10-K

SNYR shows concerning financial deterioration with revenue declining 12.8% while stockholders' equity deficit deepened significantly and total assets contracted by nearly 38%.

The company faces mounting financial stress as evidenced by the substantial asset base contraction and worsening equity position, now showing a deficit exceeding $23 million. While operating cash flow losses improved modestly, the overall trajectory suggests potential liquidity challenges and questions about the company's ability to stabilize operations.

Comparing 2026-04-01 vs 2025-03-31View on EDGAR →
FINANCIAL ANALYSIS

SNYR experienced broad-based financial deterioration with revenue falling to $30.4M and gross profit declining to $20.3M, reflecting weakening core business performance. The balance sheet contracted meaningfully with total assets dropping to $10.2M while the stockholders' equity deficit expanded to -$23.1M, indicating severe capital erosion. Despite current liabilities declining substantially, the overall picture signals a company under significant financial strain with a shrinking asset base and deepening capital shortfall.

FINANCIAL STATEMENT CHANGES
Current Liabilities
Balance Sheet
-52.1%
$17.2M$8.2M

Current liabilities reduced — improved short-term financial position and working capital health.

Operating Cash Flow
Cash Flow
+46.2%
-$4.8M-$2.6M

Operating cash flow surged 46.2% — exceptional cash generation, highest quality earnings signal.

Accounts Receivable
Balance Sheet
-39.8%
$5.3M$3.2M

Receivables declined — improved collection efficiency or conservative revenue recognition.

Stockholders Equity
Balance Sheet
-39.1%
-$16.6M-$23.1M

Equity declined sharply — large losses, buybacks, or write-downs reducing book value significantly.

Total Assets
Balance Sheet
-37.8%
$16.3M$10.2M

Total assets contracted 37.8% — asset sales, write-downs, or balance sheet optimization underway.

Current Assets
Balance Sheet
-37.6%
$16.1M$10.0M

Current assets declined 37.6% — monitor working capital adequacy and short-term liquidity.

Gross Profit
P&L
-14.1%
$23.6M$20.3M

Gross margin compression — rising input costs, pricing pressure, or unfavorable product mix shift.

Revenue
P&L
-12.8%
$34.8M$30.4M

Revenue softened 12.8% — monitor whether this is cyclical or structural.

LANGUAGE CHANGES
NEW — 2026-04-01
PRIOR — 2025-03-31
ADDED
Employer Identification No.) 770 Roosevelt Trail STE 8 #1016 N.
For the purposes of this disclosure, shares of common stock held by each executive officer, director and affiliate based on public filings and other information known to the registrant have been excluded since such persons may be deemed affiliates.
This determination of affiliate status is not necessarily a conclusive determination for other purposes.
As of March 27, 2026, there were 11,483,926 shares of common stock, par value $0.00001 per share, of the registrant issued and 11,303,853 shares outstanding.
Our current brand portfolio consists of two marquee brands, FOCUSfactor, a clinically-tested brain health supplement (this study was performed independently and is not related to any U.S.
+7 more — sign up free →
REMOVED
The registrant s common stock began trading on The Nasdaq Stock Market on October 23, 2024.
As of March 27, 2025, there were 8,752,178 shares of common stock, par value $0.00001 per share, of the registrant issued and 8,572,105 shares outstanding.
Our current brand portfolio consists of two marquee brands, FOCUSfactor, a clinically-tested brain health supplement (this study was performed independently and is not related to any FDA-approved IND application) that has been shown to improve memory, concentration and focus, and Flat Tummy, a lifestyle and wellness brand that provides a suite of nutritional products to help women achieve their nutrition and weight management goals.
Our products are sold through some of the nation s leading club, mass drug, and other retailers such as Costco, Amazon.com, Walmart, Walgreens, CVS, The Vitamin Shoppe, Target.com, H-E-B, Meijer, and Albertson s.
Additionally, we have expanded into Canada and the United Kingdom.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →